BNCT Project on Impact Assessment
OECD BNCT

Project on Impact Assessment (OECD BNCT)

For some time, analysts have predicted that biotechnology and nanotechnology would enable broad new areas of scientific research and innovation, revolutionise industrial processes, and deepen economic value chains. After many years of sustained investment by countries in these areas, many national policy makers seek better ways to measure impact of these fields. However, validation of predictions and assertions is hampered by the interdisciplinary nature of these fields and their broad diffusion as tools within other scientific areas. Growing technological convergence across these domains further confounds clear assessment of impact that policymakers are interested in.

Drawing from the strength of prior OECD work, the new OECD Working Party on Biotechnology, Nanotechnology and Converging Technologies (BNCT) aims to develop an impact assessment methodology that allows the simultaneous analysis of nanotechnology and biotechnology and the impacts of policies concerning them.

The Working Party anticipates to use the consolidated Impact Assessment of Biotechnology and Nanotechnology to understand more fully the growth dynamics of industrial sectors involving and affected by the two technologies, with a view to characterizing the development towards converging technologies.

Latest News on Impact Assessment

Happy 2016! - The Year we assess BNCT

Posted by Steffi Friedrichs on January 4, 2016

Happy New Year to all Biotechnology, Nanotechnology and Converging Technologies (BNCT) enthusiasts!

During the recent meeting of the BNCT Task Force on Measurement and Impact (TFMI), and the subsequent 2nd BNCT Meeting, it was decided that 2016 would be the year, in which we review and re-confirm relevant and comparable indicators for biotechnology, nanotechnology (and converging technologies), and develop and commence a consolidated Impact Assessment methodology of both the technologies and their underlying policies.

We will frequently update you on both the Project on Statistics & Indicators and the Project on Impact Assessment with postings of news, consultations and sneak-previews of the findings of our analyses; by way of an amuse-bouche, please have a look at your country's Revealed Technology Advantage (RTA) in Biotechnology and Nanotechnology, as one of many regularly updated statistics on the Innovation Policy Platform.

Info: Impact Assessment of Bio- and Nanotechnology

BNCT-STIP-Survey

 

All BNCT Delegations that have not yet completed and submitted their country's BNCT-STIP-Survey are asked to kindly do so ASAP.

Information should be provided by completing the generic Excel-Macro of the BNCT-STIP-Survey sent to each delegation in July 2016; the generic Excel-Macro can be downloaded here: 2016-BNCT-STIP-Survey [COUNTRY].xlsm.

In the case of problems with opening the Excel-Macro or problems with the Macro's MS Office version, please use the following Excel(97)-file instead: 2016 BNCT-STIP-Survey (previous EXCEL).xls.

 

Please send the completed BNCT-STIP-Surveys to steffi.friedrichs@oecd.org.